First case series and literature review of coronavirus disease 2019 (COVID-19) associated pulmonary tuberculosis in Southeast Asia: Challenges and opportunities
- PMID: 36495816
- PMCID: PMC9707022
- DOI: 10.1016/j.jiph.2022.11.029
First case series and literature review of coronavirus disease 2019 (COVID-19) associated pulmonary tuberculosis in Southeast Asia: Challenges and opportunities
Abstract
Background: Subclinical tuberculosis (TB) is accidentally detected by radiologic and microbiologic findings. Transmission by those with subclinical TB could delay prevention effort. However, our study demonstrated positive aspect of COVID-19 outbreak as it could allow subclinical TB to be detected faster through a chest X-Ray (CXR).
Methods: This cross-sectional cohort study aimed to report demographics, comorbidities, and outcomes related to early detection of TB among COVID-19 patients, and to elaborate the association between SARS-CoV-2 and pulmonary TB. Data of patients with SARS-CoV-2 co-infection with Mycobacterium tuberculosis (MTB) diagnosed between March 2020 - March 2022 was collected.
Results: Out of 12,275 COVID-19 patients, 26 were definitively diagnosed with MTB infection (mean age 48.16 ± 20.17 years). All cases that had suspicious CXR that were not typical for COVID-19, were tested for MTB. On average, pulmonary TB was diagnosed after admission 5(3-10) days, the treatment initiation period was 3(1-5) days from the TB diagnosis.
Conclusions: This suggests an early detection of tuberculosis among COVID-19 patients by quicker screening CXR and sputum comparing to previous symptom guided screening. Thereby reducing the chance of TB transmission demonstrated during COVID-19 pandemic. So, clinicians should be aware of pulmonary tuberculosis in COVID-19 patients with atypical radiologic findings.
Keywords: COVID-19; Mycobacterium tuberculosis; SARS-CoV-2; Subclinical tuberculosis.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest We have no conflict of interest to declare.
Figures



Similar articles
-
Diagnosis of tuberculosis among COVID-19 suspected cases in Ghana.PLoS One. 2021 Dec 28;16(12):e0261849. doi: 10.1371/journal.pone.0261849. eCollection 2021. PLoS One. 2021. PMID: 34962960 Free PMC article.
-
Undiagnosed Pulmonary Tuberculosis (TB) and Coronavirus Disease 2019 (COVID-19) in Adults Dying at Home in a High-TB-Burden Setting, Before and During Pandemic COVID-19: An Autopsy Study.Clin Infect Dis. 2023 Aug 14;77(3):453-459. doi: 10.1093/cid/ciad212. Clin Infect Dis. 2023. PMID: 37041678
-
Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.BMC Infect Dis. 2021 Jan 13;21(1):63. doi: 10.1186/s12879-020-05752-7. BMC Infect Dis. 2021. PMID: 33435896 Free PMC article.
-
Estimating the contribution of subclinical tuberculosis disease to transmission: An individual patient data analysis from prevalence surveys.Elife. 2023 Dec 18;12:e82469. doi: 10.7554/eLife.82469. Elife. 2023. PMID: 38109277 Free PMC article. Review.
-
Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection.Front Immunol. 2022 Jun 16;13:909011. doi: 10.3389/fimmu.2022.909011. eCollection 2022. Front Immunol. 2022. PMID: 35784278 Free PMC article. Review.
Cited by
-
Post-COVID-19 tuberculosis in southeastern Spain: incidence, risk factors and the role of latent tuberculosis infection screening.Rev Esp Quimioter. 2025 Mar 3;38(2):108-114. doi: 10.37201/req/111.2024. Epub 2025 Feb 6. Rev Esp Quimioter. 2025. PMID: 39927580 Free PMC article.
-
Clinical outcomes of patients with coronavirus disease 2019 and active tuberculosis co-infection in Beijing China: A retrospective single-center descriptive study.Infect Med (Beijing). 2025 Feb 18;4(1):100169. doi: 10.1016/j.imj.2025.100169. eCollection 2025 Mar. Infect Med (Beijing). 2025. PMID: 40129441 Free PMC article.
-
Characteristics of culture-negative subclinical pulmonary tuberculosis: a single-center observation.Multidiscip Respir Med. 2024 May 15;19(1):955. doi: 10.5826/mrm.2024.955. Multidiscip Respir Med. 2024. PMID: 38756043 Free PMC article.
-
The effect of corticosteroids in developing active pulmonary tuberculosis among patients with COVID-19.PLoS One. 2024 Oct 16;19(10):e0309392. doi: 10.1371/journal.pone.0309392. eCollection 2024. PLoS One. 2024. PMID: 39413068 Free PMC article.
-
Systematic review and meta-analysis of Tuberculosis and COVID-19 Co-infection: Prevalence, fatality, and treatment considerations.PLoS Negl Trop Dis. 2024 May 13;18(5):e0012136. doi: 10.1371/journal.pntd.0012136. eCollection 2024 May. PLoS Negl Trop Dis. 2024. PMID: 38739637 Free PMC article.
References
-
- Sterne J.A.C., Murthy S., Diaz J.V., Slutsky A.S., Villar J., Angus D.C., et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. Jama. 2020;324(13):1330–1341. doi: 10.1001/jama.2020.17023. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous